Related Experiment Video
Updated: Feb 21, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
[Approach to coronary artery disease in the elderly]
1Department of Cardiology, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey. ikitimur@gmail.com.
Insights
Cardiovascular disease (CVD) in older adults requires careful management. Treatment decisions for coronary artery disease (CAD) in the elderly should balance benefits against risks, considering biological age and frailty.
Area of Science:
- Geriatric Medicine
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality, particularly in individuals over 70.
- Management of coronary artery disease (CAD) in the elderly presents unique challenges compared to younger populations.
- Age itself is a significant cardiovascular risk factor, necessitating cautious pharmacological intervention thresholds.
Purpose of the Study:
- To highlight the distinct considerations for diagnosing and managing CAD in elderly patients.
- To emphasize the importance of balancing potential drug side effects with guideline-recommended optimal medical therapy.
- To advocate for personalized treatment strategies based on biological age and frailty status in geriatric CAD patients.
Main Methods:
- Review of existing literature on CVD and CAD in the elderly.
- Analysis of factors limiting the efficacy of non-invasive stress tests in this demographic.
- Discussion of evidence-based guidelines for optimal medical therapy in elderly CAD patients.
Main Results:
- Non-invasive stress testing for CAD diagnosis in the elderly is often limited by comorbidities and reduced exercise capacity.
- Optimal medical therapy is crucial for elderly CAD patients, despite potential side effects.
- Biological age and frailty are more relevant than chronological age for treatment planning.
Conclusions:
- Treatment strategies for elderly CAD patients must carefully weigh risks and benefits.
- Patient involvement in decision-making is essential for optimizing treatment outcomes.
- Personalized care considering biological age and frailty improves risk/benefit ratios in geriatric CAD management.
Abstract:
Cardiovascular disease (CVD) is the most important contributor to overall mortality in the general population. More than half of all patients dying from CVD are older than 70 years. Prevention, diagnosis and management of coronary artery disease (CAD) in the elderly population differ in many respects compared to younger patients. Age per se can contribute significantly to overall global cardiovascular risk in the elderly population: in such cases when age is the sole risk factor for CVD, threshold for initiation of pharmacological intervention should be gauged carefully to balance possible side effects and clinical benefits. The use of non-invasive stress test for the diagnosis of CAD is limited by factors like co-morbidities, diminished exercise capacity, and false negative results due to high disease prevalence. While carefully considering possible drug side effects, one should not refrain from optimal medical therapy as recommended by evidence based guidelines in the elderly CAD patients. Biological age, rather than the calendar age, as well as frailty status should be considered while planning treatment in elderly CAD patients: involvement of the patient in the decision process would be beneficial while optimizing the treatment to attain the best risk/benefit ratio in geriatric CAD subjects.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

